Horizon Discovery Takes Exclusive License for Transposon-based Gene Editing Technology Platform

Product News   Jul 05, 2017

 
Horizon Discovery Takes Exclusive License for Transposon-based Gene Editing Technology Platform
 
 
FURTHER INFORMATION
 
 
 

Related Product News

Axol Bioscience Launch Human iPSC-derived Atrial Cardiomyocytes

Product News

A consistent and reproducible model for drug development, toxicity testing and disease modelling applications.

READ MORE

ReForm Biologics Announces New Patent for Antibody-Based Therapeutics

Product News

New surfactant replacement offers a promising alternative to polysorbates for stabilizing proteins.

READ MORE

NOW Diagnostics Acquires CELLMIC Reader Technology

Product News

Strengthens rapid diagnostics and point-of-care testing capabilities.

READ MORE

Like what you just read? You can find similar content on the communities below.

Diagnostics Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE

We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy